维普中文期刊产品整合服务
9篇 您的检索式:作者名="Mozsik"
    题名 作者 年代 出处 被引量
1Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: Phenotype-genotype correlations显示文摘AIM: To determine common NOD2/CARD15 mutations and TLR4 D299G polymorphism in Hungarian patients with CD.METHODS: A total of 527 unrelated patients with CD (male/female: 265/262, age: 37.1 (SD 7.6) years) and 200 healthy subjects were included. DNA was screened for possible NOD2/CARD15 mutations by denaturing highperformance liquid chromatography (confirmed by direct sequencing). TLR4 D299G was tested by PCR-RFLP.RESULTS: NOD2/CARD15 mutations were found in 185patients (35.1%) and in 33 controls (16.5%, P<0.0001).SNP8/R702W (10.8% vs 6%, P = 0.02), SNP13/3020insC (19.4% vs 5%, P<0.0001) and exon4 R703C (2.1% vs 0%, P = 0.02) mutations were more frequent in CD, while the frequency of SNP12/G908R was not increased. The frequency of TLR4 D299G was not different (CD: 9.9% vscontrols: 12.0%). Variant NOD2/CARD15 allele was associated with an increased risk for CD (ORhet = 1.71,95%CI = 1.12-2.6, P= 0.0001, ORtwo-riskalleles = 25.2,95%CI = 4.37- , P<0.0001), early disease onset (carrier:26.4 years vs non-carrier: 29.8 years, P = 0.0006), ileal disease (81.9% vs 69.5%, OR = 1.99, 95%CI = 1.29-3.08,P = 0.02, presence of NOD2/CARD15 and TLR4: 86.7% vs64.8%), stricturing behavior (OR = 1.69, 95%CI = 1.13-2.55,P = 0.026) and increased need for resection (OR=1.71,95%CI: 1.13-2.62, P= 0.01), but not with duration, extraintestinal manifestations, familial disease or smoking. TLR4exhibited a modifier effect: age of onset in wt/TLR4 D299G carriers: 27.4 years vs NOD2mut/TLR D299G: 23 years (P= 0.06), in NOD2mut/wt: 26.7 years.CONCLUSION: These results confirm that variant NOD2/CARD15 (R702W, R703C and 3020insC) alleles are associated with earlier disease onset, ileal disease,stricturing disease behavior in Hungarian CD patients. In contrast, although the frequency of TLR4 D299G polymorphism was not different from controls, NOD2/TLR4mutation carriers tended to present at earlier age.Peter Laszlo Lakatos Laszlo Lakatos Ferenc Szalay Claudia Willheim-Polli Christoph (O|¨)sterreicher Zsolt Tulassay Tamas Molnar Walter Reinisch Janos Papp Gyula Mozsik Hungarian IBD Study Group Peter Ferenci 2005World Journal of Gastroenterology2005,11,10:14
2Mechanisms of action of retinoids in gastrointestinal mucosal protection in animals, human healthy subjects and patients 显示文摘MOZSIK G BODIS B FIGLER M 2001Life Sci2001,69,2526:1
3Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases显示文摘Silvina del Carmen Alejandra de Moreno de LeBlanc Anderson Miyoshi Clarissa Santos Rocha Vasco Azevedo Jean Guy LeBlanc Gyula Mozsik 2010Ulcers2010,,:1
4Four response stages of capsaicinsensitive primary afferent neurons to capsaicin and its analog:gastric acid seeretion,gastric mucosal damage and protection显示文摘Mozsik G Vincze A Szolcsanyi J 2001J Gastroenterol Hepatol2001,16,10:1
5Capsaicinsensitive afferent nerves in gastric mucosal damage and protection显示文摘MOZSIK G ABDLE SALAM O M E SZOLCSANYI J 0,,:1
6Mechanisms of actionof retinoids in gastrointestinal mucosal protection in animals, human healthy subjects and patients 显示文摘Mozsik G Bodis B Figler M 2001Life Sci2001,69,2526:1
7The key-role of vagal nerve and adrenals in the cytoprotection and general mucosal integrity显示文摘Mozsik G Karadi O Kiraly A 2001J Physiol Paris2001,95,16:1
8Comparative study on the lipoxygenase activities of some soybean culti- vats显示文摘Marczy J S Simon M L Mozsik L 1995Journal of Agricultural and Food Chemistry1995,43,:1
9Interdisciplinary review for correlation between the plant origin capsaicinoids, non-steroidal antiinflammatory drugs, gastrointestinal mucosal damage and prevention in animals and human beings 显示文摘Mozsik G Past T Salam OMEA 2009Inflammopharmacol2009,17,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费